U.S. Department of Health & Human Services
Open Funding Opportunities
| FOA # | FOA Title | Research Focus Area | Earliest Submission Date | Expiration Date | Posted Date Sort ascending |
|---|---|---|---|---|---|
| OTA-21-005 | HEAL Initiative: EPPIC-Net Pain Research Asset Application (OT1) | Clinical Research in Pain Management | Tue, 09/03/2019 | Tue, 09/03/2024 | Thu, 02/25/2021 |
|
no summary
|
|||||
| RFA-DA-21-030 | HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) | Fri, 02/26/2021 | Sat, 03/27/2021 | Mon, 01/11/2021 | |
|
no summary
|
|||||
| RFA-HD-21-031 | HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Sun, 02/28/2021 | Wed, 03/31/2021 | Mon, 01/11/2021 |
|
no summary
|
|||||
| RFA-DA-21-022 | HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Mon, 03/01/2021 | Thu, 04/01/2021 | Mon, 01/11/2021 |
|
no summary
|
|||||
| RFA-DA-21-029 | HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional) | Fri, 02/26/2021 | Sat, 03/27/2021 | Mon, 01/11/2021 | |
|
no summary
|
|||||
| RFA-DA-21-023 | HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Mon, 03/01/2021 | Thu, 04/01/2021 | Mon, 01/11/2021 |
|
no summary
|
|||||
| RFA-HD-21-032 | HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Sun, 02/28/2021 | Wed, 03/31/2021 | Mon, 01/11/2021 |
|
no summary
|
|||||
| RFA-DA-21-020 | HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Mon, 03/01/2021 | Thu, 04/01/2021 | Mon, 01/11/2021 |
|
no summary
|
|||||
| RFA-MH-21-145 | HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) | New Strategies to Prevent and Treat Opioid Addiction | Thu, 02/18/2021 | Fri, 03/19/2021 | Mon, 01/11/2021 |
|
no summary
|
|||||
| RFA-DA-21-021 | HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Mon, 03/01/2021 | Thu, 04/01/2021 | Mon, 01/11/2021 |
|
no summary
|
|||||
| NOT-NS-20-107 | Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | Sun, 11/15/2020 | Thu, 05/16/2024 | Mon, 10/19/2020 | |
|
no summary
|
|||||
| NCATS ASPIRE | 2020 NCATS ASPIRE Reduction-to-Practice Challenge | Preclinical and Translational Research in Pain Management | Mon, 11/30/2020 | Sun, 02/28/2021 | Wed, 09/30/2020 |
|
no summary
|
|||||
| RFA-NS-21-010 | HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) | Preclinical and Translational Research in Pain Management | Sun, 10/18/2020 | Thu, 09/08/2022 | Wed, 09/16/2020 |
|
no summary
|
|||||
| PAR-20-092 | Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) | Fri, 01/24/2020 | Fri, 09/02/2022 | Fri, 01/24/2020 | |
|
no summary
|
|||||
| RFA-NS-20-010 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-008 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-011 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-009 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Thu, 10/03/2019 |
|
no summary
|
|||||
| RFA-DA-19-020 | HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional) | Mon, 12/10/2018 | Thu, 09/09/2021 | Wed, 09/25/2019 | |
|
no summary
|
|||||
| RFA-DA-19-019 | HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional) | New Strategies to Prevent and Treat Opioid Addiction | Sun, 12/09/2018 | Thu, 09/09/2021 | Wed, 09/25/2019 |
|
no summary
|
|||||